Catalyst Wire Dossier Catalyst Wire Dossier

JNJ-31001074

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for JNJ-31001074, covering 2010-04-16 to 2016-09-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetic Drug Interaction Between Multiple Doses of JNJ-31001074 and a Single Dose of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Women [Phase 1]

See pricing